American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1/2 study of a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), BDC-1001, as a single agent and in combination with an immune checkpoint inhibitor in patients with advanced HER2-expressing solid tumors
    Meeting Abstract

    Dumbrava, E. I.; Sharma, M. R.; Carvajal, R. D.; Catenacci, D.; Emens, L. A.; Gadgeel, S. M.; Hanna, G. J.; Juric, D.; Kang, Y. K.; Lee, J.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Validation of a predictive model for potential response to neoadjuvant endocrine therapy (NET) in postmenopausal women with clinical stage II or III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC): An ALTERNATE trial analysis (Alliance A011106)
    Meeting Abstract

    Ellis, M. J.; Suman, V.; Leitch, A. M.; Sanati, S.; Vij, K.; Unzeitig, G. W.; Hoog, J.; Watson, M.; Hahn, O.; Guenther, J.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Men1611 is a PI3K α/β selective and δ sparing inhibitor with long-lasting antitumor activity in different genetic backgrounds of PIK3CA mutant breast cancer models
    Meeting Abstract

    Fiascarelli, A.; Carrisi, C.; Merlino, G.; Capano, S.; Bisignano, D.; Talucci, S.; Bressan, A.; Bellarosa, D.; Bigioni, M.; Scaltriti, M.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • The optimal living and survivorship program: Piloting a novel cancer survivorship care model
    Meeting Abstract

    Corcoran, S.; Russell, J.; Clayton, J.; Smith, A.; Keenan, K.; Robson, M.; Iyengar, N.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Fertility preservation in young women with breast cancer: Impact on treatment and outcomes
    Meeting Abstract

    Crown, A.; Muhsen, S.; Sevilimedu, V.; Kelvin, J.; Goldfarb, S. B.; Gemignani, M. L.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Pregnancy-associated breast cancer: Does timing of presentation affect outcome?
    Meeting Abstract

    Crown, A.; McCartan, D.; Curry, M.; Feldman, M.; Patil, S.; Kamer, S.; Goldfarb, S. B.; Gemignani, M.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Ceralasertib (cer) in combination with olaparib (ola) in patients (pts) with advanced breast cancer (BC): Results of phase I expansion cohorts
    Meeting Abstract

    Dean, E.; Krebs, M. G.; Im, S. A.; Campone, M.; Postel-Vinay, S.; Arkenau, T.; Lopez, J.; Abida, W.; Jodrell, D.; Lee, K. W.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Subgroup analysis of patients with brain metastases from the phase 3 ASCENT study of sacituzumab govitecan versus chemotherapy in metastatic triple-negative breast cancer
    Meeting Abstract

    Diéras, V.; Weaver, R.; Tolaney, S. M.; Bardia, A.; Punie, K.; Brufsky, A.; Rugo, H. S.; Kalinsky, K.; Traina, T.; Klein, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Secondary outcomes in a randomized controlled trial of acupuncture versus sham acupuncture and usual care in solid tumor survivors with chemotherapy-induced peripheral neuropathy
    Meeting Abstract

    Bao, T.; Baser, R.; Lin, C.; Li, Q.; Piulson, L.; Zhi, I.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Axillary recurrence is a rare event in node-positive patients. Treated with sentinel node biopsy alone after neoadjuvant chemotherapy: Results of a prospective study
    Meeting Abstract

    Barrio, A. V.; Montagna, G.; Mamtani, A.; Sevilimedu, V.; Cody, H. S. 3rd; El-Tamer, M.; Gemignani, M. L.; Heerdt, A. S.; Moo, T. A.; Pilewskie, M.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: